Collecting data on thyroid, parathyroid, and adrenal diseases
Official title: Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
Run by M.D. Anderson Cancer Center · NCT03050762 · Data updated 2026-11-12
This study is collecting health information from people with thyroid, parathyroid, and adrenal diseases to see how these conditions affect them over time.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 15000 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | October 5, 2011 |
| Main results expected | October 2026 |
| Study ends | October 2027 |
| Registry record updated | September 17, 2019 |
| Trial ID | NCT03050762 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed or suspected of having endocrine diseases who are being seen at MD Anderson.
✕Probably not a fit
Patients without a diagnosis or suspicion of endocrine disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather comprehensive data on patients with thyroid, parathyroid, and adrenal diseases. Participants will have their medical records reviewed and information entered into a research database at MD Anderson. The study will track the current or suspected illnesses, surgeries, and recoveries of participants over a period of up to 15 years, with follow-up phone calls starting 2-3 years after diagnosis or treatment. This long-term data collection will help researchers better understand these endocrine diseases.
Why it matters
Potential benefit: If successful, this study could enhance understanding of endocrine diseases, potentially leading to improved patient outcomes and treatment strategies.
How similar studies have gone: Other studies focusing on data collection for chronic diseases have shown success in improving patient care and outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients that are being seen at MD Anderson with diagnosed or suspected endocrine disease. Patients will be selected from patients undergoing evaluation and/or treatment in the Endocrine Center, either by selection from a participating Endocrine physician or by screening from study personnel for patients scheduled to be seen in the Endocrine Clinic. 2. In addition, we intend to contact family members of patients who are enrolled on the study, and found to be deceased at follow-up, to request permission to obtain cause of death, to determine whether cause of death may be related to endocrine disease. Exclusion Criteria: N/A
Where it's running
-
University of Texas MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Nancy D. Perrier, MD — M.D. Anderson Cancer Center
- Study coordinator: Nancy D. Perrier, MD
- Email: NPerrier@mdanderson.org
- Phone: 713-792-6940
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Male Hypogonadism: How Stigma and Identity relate to Quality of Life
This study tests whether men with hypogonadism feel more anticipated stigma and have a different illness identity compared with men with other chronic endocrine conditions, and whether those psychosocial factors predict quality of life.
-
Environmental and inflammatory links to metabolic and endocrine diseases
This project will see if combining environmental, genetic, and protein information can help predict early risk of diabetes, hypertension, and other metabolic or endocrine problems in community adults.
-
Steroid blood‑profile score to help diagnose mild autonomous cortisol‑secreting adrenal nodules (MACS)
This study will test if a single blood test measuring 19 steroid hormones plus basic clinical measures can distinguish people with mild autonomous cortisol secretion (MACS) from those with non‑secreting adrenal adenomas.
-
Observational study of endocrine disorders and their effects
This study looks at adults with different hormone-related disorders to better understand their conditions and improve care for them.
-
Improving diagnosis and treatment of pheochromocytoma
This study is testing new ways to find and treat pheochromocytomas, which are tumors from the adrenal glands, to help improve care for people with this condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.